Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant

Mortimer B O'Connor; Neil O'Donovan; Ursula Bond; Mark J Phelan

doi:10.1136/bcr-2016-217313

Article info

CASE REPORT

Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant

Authors

Mortimer B O'Connor Department of Medicine, Mercy University Hospital, Cork, Ireland Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland PubMed articles Google scholar articles
Neil O'Donovan Department of Radiology, South Infirmary Victoria University Hospital, Cork, Ireland PubMed articles Google scholar articles
Ursula Bond Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland PubMed articles Google scholar articles
Mark J Phelan Department of Medicine, Mercy University Hospital, Cork, Ireland Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland PubMed articles Google scholar articles

Correspondence to Dr Mortimer B O'Connor, mortimeroconnor{at}gmail.com

View Full Text

Citation

O'Connor MB, O'Donovan N, Bond U, et al

Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant

Case Reports 2017;2017:bcr2016217313.

Publication history

Accepted December 23, 2016
First published January 10, 2017.

Online issue publication

August 07, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2017 BMJ Publishing Group Ltd

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password